Experimental & Molecular Medicine (EMM) is Korea's first biochemistry journal (founded in 1964) and is relaunched in 1996 as an Open Access, fully peer-reviewed international journal. It is a medical research journal devoted to publishing the latest developments in translational research and the recent discoveries in the biomedical field. Submission is encouraged of papers that involve genetic, molecular and cellular studies of human physiology and diseases. The journal seeks to highlight the improved clinical benefits for human health from experimental and translational research performed using specific molecular tools. Studies that encompass basic discoveries with clinical relevance as well as articles dealing with clear in vivo relevance and novelty will also be welcomed. Experimental & Molecular Medicine is an open access, online-only journal. Topics of particular interest within the journal's scope include, but are not limited to, those listed below: Cancer biology Immunology Neuroscience Cardiovascular biology Genetics and genomics Gene therapy Metabolic diseases Stem cells and regenerative medicine Physiology and diseases Molecular Medicine The journal publishes peer-reviewed Original Articles and Reviews. In addition, Research Summaries are provided for selected articles. Editorial articles are brief comments written by the editor(s) of the journal or by guest editor(s) of Special Features based on the contents of the current issue or topical subjects that fall within the scope of the journal. Reviews can be submitted by authors without invitation but authors are encouraged to submit an abstract of the review to the Editor-in-Chief (dmjue@catholic.ac.kr) to consider for suitability prior to submission of a full article. Submissions of Review articles from outstanding graduate students are also encouraged under the following conditions: An abstract of the review should be submitted to the Editor-in-Chief (dmjue@catholic.ac.kr) to consider for suitability prior to the submission of a full article The student's supervisor who has the most expertise in the area being reviewed must be a participatory co-author on the paper The article should encompass a critical assessment of an area: the timeliness of this assessment should be explicitly justified.